Can I Take Creatine with Prometrium?

What Is Prometrium and Why Is It Prescribed?

Prometrium is the brand name for oral micronized progesterone, a bioidentical form of the hormone progesterone. The FDA first approved it in 1998 for two indications: prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens, and treatment of secondary amenorrhea [1]. Micronization reduces the particle size of progesterone to below 10 microns, which improves oral bioavailability compared with older synthetic progestins [2].

How Prometrium Is Metabolized

After oral ingestion, Prometrium undergoes extensive first-pass hepatic metabolism. The liver converts it primarily through CYP3A4 and, to a lesser extent, CYP1A2 into active metabolites including 5-alpha-dihydroprogesterone and allopregnanolone [3]. Allopregnanolone is a positive allosteric modulator of GABA-A receptors, which explains the sedative effect some women notice when taking Prometrium at bedtime.

The drug is excreted mainly as glucuronide conjugates in the urine. Renal impairment does not significantly alter progesterone metabolism, because the elimination route is hepatic, not renal. This distinction matters when considering creatine co-administration.

Typical Dosing Regimens

For endometrial protection on hormone replacement therapy (HRT), the standard regimen is 200 mg orally at bedtime for 12 days per 28-day cycle, or 100 mg nightly continuously. For luteal phase support in assisted reproduction, doses range from 200 mg to 600 mg daily in divided doses, often vaginally rather than orally. The FDA-approved prescribing information lists peanut oil as a capsule excipient, so patients with peanut allergy require alternative formulations [1].

What Is Creatine and How Does It Work in the Body?

Creatine is an endogenous nitrogenous compound synthesized from arginine, glycine, and methionine in the liver and kidneys. Approximately 95% of the body's creatine is stored in skeletal muscle as phosphocreatine, which rapidly regenerates ATP during high-intensity exercise [4].

Creatine Absorption and Elimination

Supplemental creatine monohydrate is absorbed from the gastrointestinal tract and taken up into muscle via the SLC6A8 creatine transporter. The small fraction not stored in muscle is filtered freely by the glomerulus and excreted in urine. Creatine spontaneously converts to creatinine at a rate of roughly 1 to 2% per day; this is why creatine loading raises serum creatinine even in individuals with entirely healthy kidneys [5].

A 2003 study by Poortmans and Francaux (N=18 healthy males, 10 weeks of creatine at 20 g/day loading then 5 g/day maintenance) found no adverse effect on glomerular filtration rate, tubular reabsorption, or urinary protein excretion [5]. The International Society of Sports Nutrition (ISSN) position stand states: "There is no compelling scientific evidence that the short or long-term use of creatine monohydrate has any detrimental effects on otherwise healthy individuals" [6].

Why Creatinine Matters on Standard Labs

Standard renal function panels estimate kidney function using serum creatinine as a surrogate for glomerular filtration rate (GFR). The CKD-EPI and MDRD equations use creatinine concentration to compute eGFR. When creatine supplementation increases serum creatinine by 10 to 20% above an individual's personal baseline, the calculated eGFR drops by a corresponding amount, even though actual kidney function has not changed [7].

For most patients on Prometrium, this is a manageable nuisance. For patients who have borderline kidney function (eGFR 45 to 60 mL/min/1.73 m²) at baseline, the artificial creatinine rise could push the calculated eGFR below a threshold that triggers clinical action.

Is There a Direct Drug-Supplement Interaction?

No pharmacokinetic interaction between creatine and Prometrium appears in the published literature, the FDA drug-interaction database, or the Natural Medicines Comprehensive Database interaction checker [8].

CYP Enzyme Considerations

Prometrium's metabolism depends on CYP3A4 and CYP1A2. Creatine is not a substrate, inhibitor, or inducer of any cytochrome P450 enzyme. In vitro studies of creatine metabolism confirm that the compound bypasses hepatic CYP pathways entirely, relying instead on the arginine:glycine amidinotransferase (AGAT) and guanidinoacetate methyltransferase (GAMT) enzymes located in the kidney and liver [4]. Because these enzymes are distinct from the CYP system, creatine supplementation does not alter the plasma half-life, Cmax, or AUC of Prometrium.

Protein Binding and Distribution

Progesterone is approximately 96 to 99% protein-bound in plasma, primarily to albumin and corticosteroid-binding globulin. Creatine does not bind to plasma proteins to a clinically relevant degree. No displacement interaction is plausible on this basis [3].

Pharmacodynamic Overlap

Progesterone and creatine operate through completely separate pharmacodynamic mechanisms. Progesterone binds nuclear progesterone receptors (PR-A and PR-B) and membrane-associated progesterone receptors to exert its endometrial and neuroactive effects. Creatine acts by replenishing the phosphocreatine pool in muscle and brain cells. No shared receptor, signaling cascade, or downstream effector has been identified that would produce additive or antagonistic pharmacodynamic effects [9].

The Creatinine Lab Interference Problem: A Practical Deep Dive

This is where clinical judgment matters. Prometrium is prescribed in the context of HRT or reproductive medicine, where clinicians often run periodic metabolic panels to assess cardiovascular and renal safety. If a patient is also taking creatine without disclosing it, an apparent eGFR decline can trigger unnecessary investigation.

How Much Does Creatine Raise Creatinine?

The magnitude of the creatinine rise depends on dose and timing. A 2021 review by Kaviani et al. In the Journal of Strength and Conditioning Research found that a 20 g/day loading phase over 5 to 7 days raised serum creatinine by a mean of 0.18 mg/dL (approximately 16% above baseline in women with a typical female baseline of 0.7 to 1.0 mg/dL) [10]. Maintenance dosing of 3 to 5 g/day raises creatinine by a smaller margin, typically 0.05 to 0.10 mg/dL above baseline.

When the Interference Becomes Clinically Relevant

For a woman with baseline serum creatinine of 0.80 mg/dL and an eGFR of 85 mL/min/1.73 m², a creatine-induced rise to 0.95 mg/dL reduces calculated eGFR to approximately 70 mL/min/1.73 m². That shift is not dangerous, but it might prompt a repeat lab draw or a nephrology referral.

For a woman already at eGFR 52 mL/min/1.73 m², the same absolute rise in creatinine could push calculated eGFR below 45 mL/min/1.73 m², crossing from CKD stage G3a into G3b. This could affect medication dosing decisions and insurance-required monitoring timelines.

Cystatin-C as the Solution

Cystatin-C is a small protein filtered by the glomerulus that is not affected by muscle mass or dietary creatine intake. The CKD-EPI cystatin-C equation produces an eGFR estimate independent of creatinine [7]. Any prescriber monitoring kidney function in a patient who supplements with creatine should use a cystatin-C-based eGFR, or at minimum be aware that the creatinine-based value is artificially depressed.

The HealthRX clinical team recommends the following decision framework for Prometrium patients who want to use creatine:

1. Disclose creatine use to your HRT prescriber at every relevant visit.
2. Request a baseline cystatin-C eGFR before starting creatine if your current creatinine-based eGFR is below 70 mL/min/1.73 m².
3. Use maintenance dosing (3 to 5 g/day) rather than a loading phase if you have any history of kidney stones, reduced GFR, or protein in your urine.
4. Re-check creatinine and cystatin-C together at your first monitoring visit after starting creatine, so your clinician can calculate the delta and attribute any change correctly.
5. If cystatin-C eGFR is stable but creatinine-based eGFR appears reduced, document the creatine use in the medical record so the discrepancy does not trigger unnecessary workup at future labs.

Creatine in Perimenopausal and Postmenopausal Women: The Emerging Evidence

Most creatine research has been conducted in young male athletes. The evidence base in the population most likely to be taking Prometrium (perimenopausal and postmenopausal women) is smaller but expanding.

Muscle and Bone Outcomes

A randomized controlled trial by Chilibeck et al. (N=237 postmenopausal women, 52 weeks) found that creatine supplementation combined with resistance training produced greater gains in lean mass and bone mineral density at the femoral neck compared with placebo plus resistance training. The mean lean mass gain in the creatine group was 1.37 kg vs. 0.82 kg in placebo (P<0.05) [11]. Given that estrogen decline accelerates sarcopenia and bone loss, this finding is relevant to women on HRT.

Brain Health

Progesterone and its neurosteroid metabolite allopregnanolone have established neuroprotective roles. Creatine also has a well-documented role in brain energy metabolism. A 2022 review in Nutrients noted that creatine supplementation at 20 g/day for 5 days improved cognitive performance on working memory tasks in sleep-deprived adults [9]. Whether creatine and Prometrium's allopregnanolone metabolite produce additive neuroprotective effects has not been studied in a prospective trial, but no antagonistic interaction has been proposed either.

Safety Profile in Women

The ISSN position stand, updated in 2017, reviewed over 500 studies and concluded that creatine monohydrate is the most effective ergogenic nutritional supplement for increasing high-intensity exercise capacity and lean body mass [6]. Among female-specific cohorts, no estrogen-progesterone drug interaction was identified. Adverse effects in women are similar to those in men: mild gastrointestinal discomfort in a minority of users, primarily during loading phases.

Does Prometrium Affect Creatine's Effectiveness?

Progesterone does not meaningfully affect skeletal muscle creatine uptake. The SLC6A8 transporter that moves creatine into muscle cells is regulated primarily by insulin and IGF-1 signaling, not by sex steroids [4]. Estradiol has a modest positive effect on muscle creatine transport in animal models, but progesterone's contribution to this pathway is not established in human data.

Insulin Sensitivity Considerations

Prometrium (micronized progesterone) has a more favorable metabolic profile than synthetic progestins such as medroxyprogesterone acetate (MPA). The PEPI trial (N=875) demonstrated that micronized progesterone did not adversely affect fasting insulin or glucose metabolism over 3 years, unlike MPA [12]. Because creatine uptake into muscle depends on insulin-mediated transport, a neutral effect of Prometrium on insulin sensitivity means creatine's ergogenic mechanism is not blunted by the co-administration of Prometrium.

Timing, Dosing, and Practical Guidance

Should You Separate Dosing Times?

No. Because there is no pharmacokinetic or pharmacodynamic interaction, dose-separation windows are not necessary. Prometrium taken at bedtime and creatine taken post-workout or with breakfast do not interfere with each other's absorption or action.

What Dose of Creatine Is Appropriate?

The ISSN recommends 3 to 5 g/day of creatine monohydrate as a maintenance dose for most adults [6]. If you choose a loading phase (20 g/day in 4 divided doses for 5 to 7 days), alert your prescriber so that any creatinine lab drawn during or shortly after that phase is interpreted correctly. The creatinine elevation from a loading phase typically resolves within 4 to 6 weeks of returning to maintenance dosing.

Hydration

Creatine draws water into muscle cells and can modestly reduce plasma volume if fluid intake is inadequate. Prometrium does not have a diuretic effect, so this is not an additive concern. Standard guidance applies: aim for adequate daily fluid intake, particularly during exercise.

Kidney Stone History

Creatine is metabolized to creatinine and does not directly form kidney stones. Despite early case reports, a systematic review found no increase in urolithiasis risk with creatine supplementation at standard doses [5]. If you have a history of calcium oxalate stones, discuss the decision with your urologist, but Prometrium co-administration does not modify this risk.

When to Contact Your Prescriber

Contact your prescribing clinician before starting creatine if any of the following apply:

• Your most recent creatinine-based eGFR is below 60 mL/min/1.73 m².
• You have a known diagnosis of chronic kidney disease (any stage).
• You have type 1 or type 2 diabetes with documented microalbuminuria.
• You are on a loading phase of 20 g/day and your next lab draw is within 8 weeks.

None of these situations are absolute contraindications to creatine use, but they each call for adjusted monitoring rather than avoidance.

Summary of the Interaction Profile

| Feature | Status | |---|---| | CYP enzyme interaction | None identified | | Protein-binding displacement | None identified | | Pharmacodynamic conflict | None identified | | Lab interference (creatinine) | Yes, clinically manageable | | Effect on Prometrium efficacy | None identified | | Effect on creatine efficacy | None identified | | Monitoring required | Cystatin-C eGFR if baseline eGFR <70 |